Share tips of the week, 9 July
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Entain
The Sunday Times
Sports betting and gambling company Entain rejected a bid from US casino giant MGM six months ago but the Americans look set to return with a better deal. Entain has performed well in recent months. Its joint venture with MGM, BetMGM, grew its net gaming revenue by 400% year-on-year between September 2020 and March 2021. Entain is also addressing its “image problem”: it will exit unregulated markets and drop the “tainted” GVC brand. Investors should place their bets now. 1,797p
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
FedEx
Investors’ Chronicle
The pandemic greatly accelerated the shift towards e-commerce, and delivery companies have reaped the benefits. FedEx “has thrived” during the pandemic. Sales jumped by over a fifth to a record $84bn in the year to 31 May thanks to higher parcel volumes in its domestic market. FedEx Ground, which delivers small packages, saw operating profit jump by nearly 60% to $3.2bn. FedEx Express, the firm’s larger business and international parcel courier, “has been capitalising on the “collapse” in commercial air travel. $303.69
Glencore
The Mail on Sunday
Investing in coal might raise a few eyebrows, but Glencore is “doing its best to deal with environmental liabilities”. It recently acquired a “huge” Colombian coal mine, Cerrejon. Though the use of thermal coal is declining in the West, global demand over the next five years is expected to be stable thanks to South East Asia. Glencore is also a major producer of copper and cobalt, which make the batteries that store renewable energy. 321p
Three to sell
CureVac
Motley Fool
The German government invested over €300m in CureVac’s vaccine candidate. But the firm says the final late-stage clinical data was “disappointing”. The vaccine has just 48% overall efficacy against the virus in all age groups and it was not especially successful in preventing serious symptoms among those aged 60 and above. Yet the shares are trading as if the vaccine had succeeded. Investors should avoid them. $64.76
Burberry
The Sunday Telegraph
Burberry CEO Marco Gobbetti’s departure has wiped £1bn off the firm’s market value. That’s partly because investors recognise his abilities, but also because his work at the fashion group was “not complete” after a “partially successful brand turnaround”. Replacing him may not be easy – a luxury house “will not prosper without a wellspring of creative energy” working harmoniously with “business brains”. Burberry faces two big challenges: it must catch up in leather goods and handbags, where it still lags rivals; and improve sales per square foot of retail space. Though “another good hire” is probably on the cards, it will be “several years” before results begin to show. Sell. 2,049p
Genius Sports
Barron’s
Sports data and technology firm Genius Sports merged with a special purpose acquisition company (Spac) to float in April: online sports betting is being legalised throughout the US. It is valued at $5.4bn, a hefty 20 times this year’s sales and so far, it is unprofitable. Yet it has also just signed a six-year deal to become the exclusive gambling-data partner of the National Football League, agreeing to pay a “steep” $120m a year. Avoid. $19.32
...and the rest
The Daily Telegraph
Analysts expect housebuilder Crest Nicholson’s earnings-per-share to rebound from a loss in 2020 to 27p in 2021, 34p in 2022, and 41p in 2023. The company “still appears to offer long-term value”, so hold onto the shares (429p). JP Morgan’s variety of services, including investment banking and wealth management, make it a more appealing investment than other “plain vanilla” retail banks. The group’s sales have grown by 28% over the last five years and the stock allows investors to “play the growth in US banking”. Buy ($154).
Shares
Car retailer Motorpoint’s shares have jumped by 93% in a year. The group has just produced solid full-year results to 16 June and is encouraged by growth in online sales. It is now investing in technology, marketing, data and expansions to keep the momentum going. Buy (367p). Food producer Tate & Lyle is also a buy, having generated a “healthy” return on equity of 18% for the year to March 2021, showing its “resilience” to the pandemic 762p).
Investors’ Chronicle
Data analysis company D4T4 Solutions’ “fast-growing cost base” weighed on its earnings for the year to March. But its core businesses “appear to be trading well”. Hold (348p).
Barron’s
A summer rebound for airlines isn’t guaranteed, but shares of International Consolidated Airlines Group, Ryanair and Wizz Air seem “inviting”. They have limited exposure to corporate travel, which is set to remain weak, and they should recover with recreational travel. “Consider jumping aboard” while they’re cheap. Buy (190p, €16.90, 4,896p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published